Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
BioGaia AB (publ)
BGLAFBioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden. Address: Kungsbroplan 3, Stockholm, Sweden, 112 27
Analytics
Zielpreis von Wall Street
1 747.42 SEKKGV
32.2755Dividendenrendite
1.78 %Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen BGLAF
Dividenden-Analyse BGLAF
Dividendenwachstum über 5 Jahre
68 %Kontinuierliches Wachstum
2 JahreAusschüttungsquote 5-Jahres-Durchschnitt
34 %Verlauf der Dividende BGLAF
Bewertung der Aktie BGLAF
Finanzen BGLAF
Ergebnisse | 2019 | Dynamik |